| Q37116064 | Developmental and Functional Effects of Steroid Hormones on the Neuroendocrine Axis and Spinal Cord |
| Q37137776 | Endogenous progesterone levels and frontotemporal dementia: modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model. |
| Q36980880 | Estrogens and progesterone as neuroprotectants: what animal models teach us |
| Q38471584 | Experimental and clinical evidence for the protective role of progesterone in motoneuron degeneration and neuroinflammation |
| Q36087937 | Identification of pharmacological targets in amyotrophic lateral sclerosis through genomic analysis of deregulated genes and pathways. |
| Q37822795 | Menopause and mental well-being: timing of symptoms and timing of hormone treatment |
| Q28580830 | Neurogenic pain and steroid synthesis in the spinal cord |
| Q36511922 | Neuroprotection by ovarian hormones in animal models of neurological disease |
| Q30480195 | New insights into mitochondrial structure during cell death |
| Q38866162 | Oestrogens and Progestagens: Synthesis and Action in the Brain. |
| Q21266563 | Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis |
| Q47855578 | Progesterone analogue protects stressed photoreceptors via bFGF-mediated calcium influx. |
| Q38332083 | Progesterone and 17β-estradiol increase differentiation of mouse embryonic stem cells to motor neurons. |
| Q36306281 | Progesterone and neuroprotection |
| Q42714238 | Progesterone attenuates several hippocampal abnormalities of the Wobbler mouse |
| Q44969180 | Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice |
| Q37422665 | Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. |
| Q34895372 | Progesterone prevents development of neuropathic pain in a rat model: Timing and duration of treatment are critical |
| Q42719175 | Progesterone prevents mitochondrial dysfunction in the spinal cord of wobbler mice |
| Q38103622 | Progesterone protective effects in neurodegeneration and neuroinflammation |
| Q38829565 | Progesterone receptor signalling in retinal photoreceptor neuroprotection |
| Q28274391 | Progesterone receptors: form and function in brain |
| Q36457288 | Progesterone treatment of spinal cord injury: Effects on receptors, neurotrophins, and myelination |
| Q43239575 | Progesterone, BDNF and neuroprotection in the injured CNS. |
| Q36640264 | Progesterone, brain-derived neurotrophic factor and neuroprotection |
| Q36511934 | Progesterone-induced neuroprotection |
| Q36902093 | Progesterone-induced neuroprotection: factors that may predict therapeutic efficacy |
| Q48121748 | Reduced GABAergic inhibition explains cortical hyperexcitability in the wobbler mouse model of ALS. |
| Q33864547 | Sex differences in cognitive impairment and Alzheimer's disease |
| Q91123514 | Sex differences in steroid levels and steroidogenesis in the nervous system: Physiopathological role |
| Q43289273 | Stage dependent effects of progesterone on motoneurons and glial cells of wobbler mouse spinal cord degeneration |
| Q27663283 | Structural basis for the wobbler mouse neurodegenerative disorder caused by mutation in the Vps54 subunit of the GARP complex |
| Q36652633 | The Effects of Progesterone on Glial Cell Line-derived Neurotrophic Factor Secretion from C6 Glioma Cells. |
| Q34219234 | The biochemistry of neuronal necrosis: rogue biology? |
| Q33822501 | The stress response factor daf-16/FOXO is required for multiple compound families to prolong the function of neurons with Huntington's disease |
| Q38805145 | The synthetic progesterone Norgestrel is neuroprotective in stressed photoreceptor-like cells and retinal explants, mediating its effects via basic fibroblast growth factor, protein kinase A and glycogen synthase kinase 3β signalling. |
| Q36878198 | The wobbler mouse, an ALS animal model |